TrialAntiviral therapy2016

The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.

Donald P Kotler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.